Clinical Trials
246
Active:5
Completed:143
Trial Phases
5 Phases
Phase 1:8
Phase 2:11
Phase 3:6
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (169 trials with phase data)• Click on a phase to view related trials
Not Applicable
105 (62.1%)Phase 4
39 (23.1%)Phase 2
11 (6.5%)Phase 1
8 (4.7%)Phase 3
6 (3.6%)Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study
Not Applicable
Recruiting
- Conditions
- Rehabilitation OutcomeCerebrolysinIschemic Stroke, Acute
- Interventions
- Drug: Cerebrolysin treatmentDrug: The patients in Arm 1 will be treated with cerebrolysin and standard treatment.Other: Standard treatment (including neurorehabilitation) of acute ischemic stroke
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-07-09
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 30
- Registration Number
- NCT07043686
- Locations
- 🇸🇮
UMC Ljubljana - Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT), Ljubljana, Slovenia
Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Introduction of HPV Vaccination
Not Applicable
Recruiting
- Conditions
- Cervical Cancer ScreeningVaccination Uptake
- Interventions
- Biological: Offering HPV vaccine
- First Posted Date
- 2025-05-29
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 500
- Registration Number
- NCT06995157
- Locations
- 🇸🇮
UMC Ljubljana, Ljubljana, Domzale, Slovenia
Endocrine Disruptors, Toxic and Essential Chemical Elements and Polycystic Ovary Syndrome
Completed
- Conditions
- Polycystic Ovary Syndrome
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 70
- Registration Number
- NCT06968455
- Locations
- 🇸🇮
Division of Ob/Gyn, University Medical Centre Ljubljana, Ljubljana, Slovenia
Anti-phospolipid Antibodies in Lyme Borreliosis
Not yet recruiting
- Conditions
- Patients With Different Manifestations of Lyme BorreliosisPersons With Nonspecific Symptoms and Positive Borrelia Antibodies in SerumBlood Donors
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 240
- Registration Number
- NCT06929546
- Locations
- 🇸🇮
University Medical Center Ljubljana, Ljubljana, Slovenia
Correlation Between Base Excess in Patients Upon Admission to the ICU and Platelet Count Trend in the Following Days
Completed
- Conditions
- Platelet Count Decline in Critically IllMetabolic AcidosisMetabolic Acidosis SeverityPlatelet Count Decline in ICU Patients
- First Posted Date
- 2025-04-03
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 484
- Registration Number
- NCT06908408
- Locations
- 🇸🇮
University Medical Centre Ljubljana, Zaloška cesta 7, 1000 Ljubljana, Slovenia, Ljubljana, Slovenia
- Prev
- 1
- 2
- 3
- 4
- 5
- 50
- Next
News
No news found